These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10829241)

  • 21. The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma.
    Airenne S; Surcel HM; Bloigu A; Laitinen K; Saikku P; Laurila A
    APMIS; 2000 Feb; 108(2):139-44. PubMed ID: 10737459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.
    Rupp J; Hellwig-Burgel T; Wobbe V; Seitzer U; Brandt E; Maass M
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3447-52. PubMed ID: 15722416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60.
    Hirono S; Dibrov E; Hurtado C; Kostenuk A; Ducas R; Pierce GN
    Circ Res; 2003 Oct; 93(8):710-6. PubMed ID: 14500333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris].
    Bauriedel G; Andrié R; Likungu JA; Welz A; Braun P; Welsch U; Lüderitz B
    Dtsch Med Wochenschr; 1999 Nov; 124(47):1408-13. PubMed ID: 10605420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.
    Di Pietro M; Filardo S; De Santis F; Sessa R
    Int J Mol Sci; 2013 Jul; 14(7):15105-20. PubMed ID: 23877837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice.
    May AE; Redecke V; Grüner S; Schmidt R; Massberg S; Miethke T; Ryba B; Prazeres da Costa C; Schömig A; Neumann FJ
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):789-94. PubMed ID: 12663369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.
    Yang X; Coriolan D; Schultz K; Golenbock DT; Beasley D
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2308-14. PubMed ID: 16179594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.
    Kern JM; Maass V; Rupp J; Maass M
    Thromb Haemost; 2009 Oct; 102(4):743-53. PubMed ID: 19806261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae.
    Lin TM; Campbell LA; Rosenfeld ME; Kuo CC
    J Infect Dis; 2000 Mar; 181(3):1096-100. PubMed ID: 10720536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia pneumoniae and atherosclerosis: links to the disease process.
    Byrne GI; Kalayoglu MV
    Am Heart J; 1999 Nov; 138(5 Pt 2):S488-90. PubMed ID: 10539855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].
    Stille W; Dittmann R
    Herz; 1998 May; 23(3):185-92. PubMed ID: 9646100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atherosclerosis as an infectious disease].
    Visseren FL; Erkelens DW
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):291-5. PubMed ID: 10221083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells.
    Wolf K; Fischer E; Hackstadt T
    Infect Immun; 2005 Aug; 73(8):4560-70. PubMed ID: 16040967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia pneumoniae multiplies in human endothelial cells in vitro.
    Kaukoranta-Tolvanen SS; Laitinen K; Saikku P; Leinonen M
    Microb Pathog; 1994 Apr; 16(4):313-9. PubMed ID: 7968460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydia pneumoniae infection is not an independent risk factor for arterial disease.
    Haberbosch W; Jantos C
    Herz; 2000 Mar; 25(2):79-83. PubMed ID: 10829243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?
    Mahony JB; Coombes BK
    FEMS Microbiol Lett; 2001 Apr; 197(1):1-9. PubMed ID: 11287138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens.
    Apfalter P; Loidl M; Nadrchal R; Makristathis A; Rotter M; Bergmann M; Polterauer P; Hirschl AM
    Eur J Clin Microbiol Infect Dis; 2000 Apr; 19(4):305-8. PubMed ID: 10834822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.
    Dittrich R; Dragonas C; Mueller A; Maltaris T; Rupp J; Beckmann MW; Maass M
    Biochem Biophys Res Commun; 2004 Jun; 319(2):501-5. PubMed ID: 15178434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery.
    Yamashita K; Ouchi K; Shirai M; Gondo T; Nakazawa T; Ito H
    Stroke; 1998 Apr; 29(4):773-8. PubMed ID: 9550510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atherosclerosis--a chronic infectious disease caused by Chlamydia pneumoniae].
    Stille W; Stephen C
    Versicherungsmedizin; 1999 Mar; 51(1):12-7. PubMed ID: 10200611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.